Introduction
The insight that HIV RNA plasma viral load (VL) suppression through optimal adherence to antiretroviral therapy (ART) dramatically reduces the risk of onward HIV transmission (Grulich et al., 2015; Cohen et al., 2015; Montaner et al., 2006; Rodger et al., 2014) has led to the implementation of Treatment-as-Prevention (TasP)-based strategies in many settings worldwide (WHO, 2012) . This approach seeks to normalize HIV testing and to facilitate and support immediate access to HIV treatment and care (Montaner et al., 2010b) , and has been shown to reduce HIV/AIDS morbidity, mortality and viral transmission (Montaner et al., 2010a (Montaner et al., , 2010b . However, structural barriers continue to limit the full realization of the individual and community-level benefits of early and sustained ART exposure among people living with HIV (PLWH), particularly within marginalized and criminalized communities (Milloy, Montaner, & Wood, 2014; UNAIDS, 2014) . In at least 61 countries, PLWH have been prosecuted for HIV transmission, exposure, or non-disclosure (Bernard & Cameron, 2016) . Punitive criminal and HIV-specific laws may directly undermine HIV prevention and treatment efforts to normalize HIV (Moyer & Hardon, 2014) .
The criminalization of HIV non-disclosure has been shown to represent a structural barrier to the healthcare engagement of PLWH (Mykhalovskiy, 2015; O'byrne, Bryan, & Roy, 2013a; Patterson et al., 2015b) . The tension between public health and criminal justice system approaches to HIV prevention is arguably most acutely felt by marginalized and otherwise criminalized groups, including PLWH who use illicit drugs. Studies consistently show that exposure to the criminal justice system is one of the most important barriers to engagement with HIV treatment and care (Cescon et al., 2011; Small, Kerr, Charette, Schechter, & Spittal, 2006 , Suárez-García et al., 2016 Werb et al., 2008) . People who use illicit drugs confront intersecting axes of disadvantage and stigma, experience high levels of surveillance from the criminal justice system, and face considerable social and structural barriers to retention in HIV treatment and care (Cescon et al., 2011; Kuchinad et al., 2016; Small et al., 2006; Suárez-García et al., 2016; Werb et al., 2008) .
Among countries with a history of prosecutions for HIV nondisclosure, exposure or transmission, Canada has one of the most aggressive approaches to the use of the criminal law against PLWH (Bernard & Bennett-Carlson, 2012) . At least 181 people have faced charges for HIV non-disclosure since the late 1980s (Patterson et al., 2016) , with socio-economically marginalized individuals overrepresented (Canadian HIV/Aids Legal Network, 2014). In the absence of HIV-specific laws, Canadian prosecutors apply existing criminal laws (predominantly sexual assault laws) to cases of HIV non-disclosure, guided nationally by precedents set by the Supreme Court of Canada (SCC). In October 2012, the SCC set a new legal test to guide HIV non-disclosure prosecutions (Supreme Court of Canada, 2012a , 2012b , ruling that PLWH who fail to disclose their HIV status to sexual partners before sex that poses a "realistic possibility" of HIV transmission could be convicted of aggravated sexual assault. The court clarified that condom-protected vaginal sex with a low plasma HIV RNA VL (defined by the court as below 1500 copies/mL) would be sufficient to avoid the legal obligation to proactively disclose to sexual partners. While the SCC suggested that the interpretation of the "realistic possibility" test may vary based on case-specific circumstances and scientific advances (Supreme Court of Canada, 2012b) (and lower courts have deviated from the SCC's ruling (Provincial Court of Nova Scotia, 2013)) PLWH must assume the strictest interpretation to protect themselves from prosecution.
In releasing its 2012 ruling, the SCC increased the reach of criminal liability for HIV non-disclosure in Canada past that which was previously established by the SCC in its 1998 ruling in R v. Cuerrier (Grant, 2013; Supreme Court of Canada, 1998) . Clinicians, public health experts, and human rights activists have criticised the SCC's ruling that both condom use and a low VL are required to avoid a "realistic possibility" of HIV transmission, maintaining that this ruling is based on conceptions of HIV transmission risk inconsistent with scientific evidence (Canadian HIV/Aids Legal Network et al., 2012; Kazatchkine, Bernard, & Eba, 2015; Loutfy et al., 2014) , and cautioning that this revised legal test may disproportionately impact the most marginalized PLWH, who experience barriers to effective engagement with HIV treatment and care (Symington, 2013) .
Canadian healthcare providers have expressed concern over suboptimal awareness and understanding of the current legal obligation to disclose HIV serostatus to sexual partners among PLWH (Savage, Braund, & Stewart, 2014) . However, awareness and understanding of the legal obligation to disclose HIV serostatus to sexual partners remain largely unexplored among the most marginalized Canadian PLWH (Patterson et al., 2015b) . Furthermore, few studies have directly explored opinions of PLWH regarding the preferred role of health and social care providers in providing information and support around HIV disclosure and the law. There is an urgent need to clarify the extent to which Canadian PLWH who use illicit drugs are aware of the current legal obligation to disclose to sexual partners, to inform public health policies and strategies to advance health and rights in the current legal climate among this marginalized and otherwise criminalized population.
To address this need, we used data from a community-recruited cohort of PLWH using illicit drugs in Vancouver to determine the prevalence and correlates of awareness of the 2012 SCC ruling on HIV non-disclosure. We also assessed sources of information and completeness of understanding of the legal obligation to disclose, and determined the preferred role of healthcare providers in discussions around HIV disclosure and the law.
Methods

Data sources
We used data from the AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS), an ongoing prospective cohort of PLWH in Vancouver who have used illicit drugs (Strathdee et al., 1998) . Individuals were eligible for the study if they were HIV-positive, aged at least 18 years and had used illicit drugs other than cannabis at least once in the 30 days before completing the baseline survey. Participants were recruited from community settings by word-ofmouth, postering and extensive street-based outreach in Vancouver's Downtown Eastside (DTES) area, the epicenter of an extensive HIV outbreak among people who use injection drugs beginning in the mid-1990s (Patrick et al., 1997) . In recent years, it has also been the setting of an ongoing TasP-based initiative to scale up HIV testing and ART uptake, particularly among illicit drug users (Montaner et al., 2010a (Montaner et al., , 2010b . The DTES has an active open drug market, in addition to high levels of drug use, homelessness and poverty.
At baseline and during semi-annual study visits, ACCESS participants complete an interviewer-administered questionnaire, which elicits information on lifetime and recent characteristics, behaviours and exposures. Participants also receive an examination from a nurse, which includes HIV clinical monitoring. A longitudinal HIV clinical profile is available for ACCESS participants through a confidential linkage to the Drug Treatment Program (DTP), housed at the BC Centre for Excellence in HIV/AIDS in Vancouver. The DTP administers all HIV/AIDS treatment, including medications and clinical monitoring, free of charge to PLWH in BC through a universal healthcare program (Patterson et al., 2015a) .
Data collection instrument
To collect participant information on awareness and understanding of the 2012 SCC ruling on HIV non-disclosure, a novel supplementary survey was devised in collaboration with community and legal partners. Questions were selected following a comprehensive literature review (Patterson et al., 2015b ) and community consultation. The content and wording of the survey questions were community-driven, and proposed questions were piloted with ACCESS frontline research staff prior to use, to identify and remedy problems with question comprehensibility and flow. Interviewers underwent training on the criminalization of HIV non-disclosure in Canada to ensure their own understanding of the case law. Referral services and information on HIV disclosure and the law were made available to participants (Canadian HIV/Aids Legal Network, 2014; Positive Living Society of British Columbia, 2015) .
Ethical considerations
The ACCESS study and supplement were reviewed and approved by the University of British Columbia/Providence
